The nation of Zimbabwe has declined a major US healthcare agreement worth $367m (272 million pounds) over five years over Washington's request for confidential biological samples.
This move came to light following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
A government representative later stated that the US was demanding access to genetic material for research and commercial purposes but was not willing to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for more dialogue to find a agreement acceptable to both sides so the country's vital HIV programme can proceed.
Broader Implications
This rejection follows a similar situation in Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of citizens' health data.
After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and accountability.
Based on statements, 16 nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no corresponding guarantee of access to any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our people if a future disease outbreak arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks previously established through the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This framework is designed to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome further dialogue with our US partners on how subsequent co-operation might be designed in a way that honours the sovereignty and interests of both nations."
Health Experts Reaction
A leading public health body stated it recognised the government's concerns, but urged that talks must proceed since a large portion of the nation's HIV programmes relied on international support.
"Where specific concerns exist, such as those involving information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it commented.
The halted deal highlights the complex debate between receiving crucial foreign assistance and protecting a country's data in an ever more interconnected world.